Company / Interest Expense
AbbVie Interest Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$2.9B
FY2025
5-year range
$2.2B / $2.9B
FY2021-FY2025
Trend
+3.0%
vs FY2024
Sector context
#1 of 42
Health Care
What the data says
Among 42 Health Care companies, AbbVie is in the bottom 2% for interest expense. Increased from $2.2B to $2.9B over the past 2 years.
Based on SEC 10-K filings.
$2.9B in FY2025 with a 5-year CAGR of +3.3%. Ranks 1st among 42 companies in Health Care.
Increased from $2.2B to $2.9B over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +9.1%
- 5-Year CAGR
- +3.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 42This company $2.9B Sector average $305.3M
▼
+847.5% above sector average
Key checks
Key Insights
- 5-year CAGR of +3.3%, indicating consistent growth.
- In FY2025, interest expense increased 3.0% year-over-year.
- Ranks #1 out of 42 companies in the Health Care sector.
- Lowest interest expense in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.9B | +3.0% |
| FY2024 | $2.8B | +26.3% |
| FY2023 | $2.2B | -0.3% |
| FY2022 | $2.2B | -8.0% |
| FY2021 | $2.4B | -1.3% |
| FY2020 | $2.5B | +37.6% |
| FY2019 | $1.8B | +32.3% |
| FY2018 | $1.3B | +17.2% |
| FY2017 | $1.1B | +9.8% |
| FY2016 | $1.0B | +45.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026